Statistically Optimized Production of Saccharides Stabilized Silver Nanoparticles Using Liquid–Plasma Reduction Approach for Antibacterial Treatment of Water

Altaf, Noor Ul Huda; Naz, Muhammad Yasin; Shukrullah, Shazia; Bhatti, Haq Nawaz; Irfan, Muhammad; Alsaiari, Mabkhoot A.; Rahman, Saifur; Niazi, Usama Muhammad; Glowacz, Adam; Proniewska, Klaudia; Wzorek, Lukasz

Various conventional approaches have been reported for the synthesis of nanomaterials without optimizing the role of synthesis parameters. The unoptimized studies not only raise the process cost but also complicate the physicochemical characteristics of the nanostructures. The liquid–plasma reduction with optimized synthesis parameters is an environmentally friendly and low-cost technique for the synthesis of a range of nanomaterials. This work is focused on the statistically optimized production of silver nanoparticles (AgNPs) by using a liquid–plasma reduction process sustained with an argon plasma jet. A simplex centroid design (SCD) was made in Minitab statistical package to optimize the combined effect of stabilizers on the structural growth and UV absorbance of AgNPs. Different combinations of glucose, fructose, sucrose and lactose stabilizers were tested at five different levels (−2, −1, 0, 1, 2) in SCD. The effect of individual and mixed stabilizers on AgNPs growth parameters was assumed significant when p-value in SCD is less than 0.05. A surface plasmon resonance band was fixed at 302 nm after SCD optimization of UV results. A bond stretching at 1633 cm(−1) in FTIR spectra was assigned to C=O, which slightly shifts towards a larger wavelength in the presence of saccharides in the solution. The presence of FCC structured AgNPs with an average size of 15 nm was confirmed from XRD and EDX spectra under optimized conditions. The antibacterial activity of these nanoparticles was checked against Staphylococcus aureus and Escherichia coli strains by adopting the shake flask method. The antibacterial study revealed the slightly better performance of AgNPs against Staph. aureus strain than Escherichia coli.